Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Press Releases.
Press releases published on May 19, 2025
Arbor Biotechnologies Appoints Don Haut, Ph.D., as Chief Business Officer
GlobeNewswire
·
May 19, 2025
CAMBRIDGE, Mass., May 19, 2025 (GLOBE NEWSWIRE) -- Arbor Biotechnologies, Inc., a biotechnology company discovering and developing the next generation of genetic medicines, today announced the appointment of Don Haut, Ph.D., as Chief Business Officer. In …
Viomi Unveils Next-Generation Mineral Water Purifiers, Leading Household Drinking Water into the Era of Pure Mineral Water
GlobeNewswire
·
May 19, 2025
GUANGZHOU, China, May 19, 2025 (GLOBE NEWSWIRE) -- Viomi Technology Co., Ltd (“Viomi” or the “Company”) (NASDAQ: VIOT), a leading technology company for home water solutions in China, today announced the official launch of its groundbreaking Kunlun 4 Pro …
NOTICE TO DISREGARD -- Lexo
GlobeNewswire
·
May 19, 2025
Denver, May 19, 2025 (GLOBE NEWSWIRE) -- We are advised by Lexo that journalists and other readers should disregard the news release, “Leading a New Era of Safe and Innovative Trading in Switzerland - LEXO Releases System Security Update” issued May 15, …
Qualifacts and Greenspace Health Announce Strategic Partnership to Advance Measurement-Based Care in Behavioral Health
GlobeNewswire
·
May 19, 2025
NASHVILLE, TN …
Duke Robotics Strengthens Global Growth Strategy with Appointment of Yuval Hogeg as International Business Development Director
GlobeNewswire
·
May 19, 2025
FT. LAUDERDALE, FL, May 19, 2025 (GLOBE NEWSWIRE) -- Duke Robotics Corp. (OTCQB:DUKR) (“Duke Robotics” or the “Company”), a leader in advanced robotics technology and autonomous drone solutions, today announced the appointment of Mr. Yuval Hogeg as the …
Phase II Data in Treatment-Naïve Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients: Ruxoprubart Demonstrates Best-in-Class Efficacy as Monotherapy
GlobeNewswire
·
May 19, 2025
--- Ruxoprubart (NM8074) met all clinical endpoints, offering a safe, differentiated treatment for Paroxysmal Nocturnal Hemoglobinuria (PNH). Paroxysmal Nocturnal Hemoglobinuria (PNH) is a rare hematological (Blood) disorder. Regulatory approval for the …
Hyra Holdings Approves $500M Venture Fund and IPO Roadmap to 2030 at 2025 Annual Meeting
GlobeNewswire
·
May 19, 2025
HANOI, Vietnam, May 19, 2025 (GLOBE NEWSWIRE) -- Hyra Holdings, a global technology investment group, today announced the formal approval of the Hyra Combinator Fund, a $500 million venture initiative aimed at accelerating innovation in AI, fintech, and …
Prime Medicine Announces Breakthrough Clinical Data Showing Rapid Restoration of DHR Positivity After Single Infusion of PM359, an Investigational Prime Editor for Chronic Granulomatous Disease
GlobeNewswire
·
May 19, 2025
-- First ever clinical data supporting safety and efficacy of Prime Editing in humans -- -- Initial data from first patient dosed in Phase 1/2 trial finds single dose of PM359 led to 58% DHR positivity by Day 15 and 66% by Day 30, well above levels …
Intelligent Bio Solutions Showcases Rapid, Non-Invasive Drug Testing Capabilities in Remote Queensland Workforce Deployment
GlobeNewswire
·
May 19, 2025
NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the successful completion of a …
Tyveo Exchange Partners with WAF: Igniting a New Spark in Stock and Crypto Trading
GlobeNewswire
·
May 19, 2025
New York, NY, May 19, 2025 (GLOBE NEWSWIRE) -- In the rapidly evolving global financial landscape, the convergence of traditional finance and digital assets is emerging as a defining trend. Tyveo Exchange and WAF (WealthArc Fintech) have recently announced …
Juvena Therapeutics Announces Initiation of First-in-Human Clinical Trial of JUV-161
GlobeNewswire
·
May 19, 2025
JUV-161 is a first-in-class muscle regenerating biologic that will address myopathies starting with Myotonic Dystrophy Type 1 JUV-161 was discovered using Juvena’s proprietary JuvNET platform, an AI and stem cell secretome-based drug discovery and …
Foresight Signs Commercialization Agreement with Global Rail Tech Provider for up to $12 Million in Revenue Starting in 2026
GlobeNewswire
·
May 19, 2025
The agreement with StreamRail, a Chinese leader in rail transit technologies, aims to enhance safety and operational efficiency for urban rail transit systems Ness Ziona, Israel, May 19, 2025 (GLOBE NEWSWIRE) -- Foresight Autonomous Holdings Ltd. (Nasdaq …
FOXO TECHNOLOGIES INC.’S CRITICAL ACCESS HOSPITAL ANNOUNCES EXPANSION OF SERVICES TO INCLUDE WOUND CARE
GlobeNewswire
·
May 19, 2025
WEST PALM BEACH, FLORIDA, May 19, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “Company”) today announced that its critical access hospital, Big South Fork Medical Center in Oneida, Tennessee, is expanding its …
Link Building Agency Serpify Launches Cutting-Edge Self-Service Link Building Platform
GlobeNewswire
·
May 19, 2025
Serpify.co a Malta-based link building agency, announced its official launch of its next-generation link building service, now available through a fully self-service platform. Built specifically for SEO professionals, agencies, and growth-focused marketers …
Marker Therapeutics to Spotlight Multi-Antigen Recognizing (MAR)-T Cells in High-Profile Panel on CAR-T Cell Therapies
GlobeNewswire
·
May 19, 2025
HOUSTON, May 19, 2025 (GLOBE NEWSWIRE) -- MARKER THERAPEUTICS, INC. (Nasdaq: MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid …
ITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177
GlobeNewswire
·
May 19, 2025
GARCHING / MUNICH, Germany and SYDNEY, May 19, 2025 (GLOBE NEWSWIRE) -- ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, and Radiopharm Theranostics (ASX:RAD; NASDAQ: RADX “Radiopharm”), a developer of a world-class …
Legend Biotech to Host Investor Event During the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
GlobeNewswire
·
May 19, 2025
SOMERSET, N.J., May 19, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a live webcast event for investors on Sunday, June 1, 2025, at 6:00 p.m. CT (7:00 p.m. ET) during the …
TORRAS Redefines the iPhone Case Market with Ostand, OAir, and OFitness Series — A Fusion of Design, Durability, and Intelligent Functionality
GlobeNewswire
·
May 19, 2025
LOS ANGELES, May 19, 2025 (GLOBE NEWSWIRE) -- TORRAS, a global leader in premium mobile accessories, is once again setting new industry benchmarks with its latest iPhone case lineup, blending aesthetic elegance, user-first innovation, and intelligent …
Recludix Pharma Presents Data Demonstrating Potent Efficacy and High Selectivity of a STAT6 Inhibitor in Preclinical Asthma Model
GlobeNewswire
·
May 19, 2025
--Efficacy comparable to anti-IL4/IL13 antibody control --Achieved dose-dependent and durable target modulation in vivo without requiring degradation of STAT6 protein --Avoided broad JAK-mediated immune suppression --Data presented at the American Thoracic …
Vaidio Showcases 9th Generation Vision AI Platform at COMPUTEX 2025
GlobeNewswire
·
May 19, 2025
TAIPEI, Taiwan, May 19, 2025 (GLOBE NEWSWIRE) -- Vision AI leader Vaidio® announced today it will showcase the 9th generation of its widely-adopted AI Vision Platform at COMPUTEX 2025, taking place at the Taipei Nangang Exhibition Center from May 20 to May …